site stats

Cisplatin accord fachinfo

WebNov 30, 2024 · If cisplatin is used in combination chemotherapy, the dose of cisplatin must be reduced. A typical dose is 20 mg/m 2 or more once every 3 to 4 weeks unless in the combination therapy of small-cell and non-small-cell lung carcinoma, in which a typical dose of 80 mg/m 2 is administered. WebCisplatină Accord, 1 mg/ml, concentrat pentru soluţie perfuzabilă Producător: Substanță activa Clasa ATC Format concentrat pentru soluţie perfuzabilă Afecțiuni diverse tipuri de cancer Producător Accord Healthcare Limited Acțiune terapeutică citostatice Cuprins Ce este Cisplatină Accord şi pentru ce se utilizează

Package Insert of Accord Healthcare’s Cisplatin Injection, 1 …

WebSep 18, 2024 · Cisplatin is a medication used to manage and treat solid tumors and hematologic malignancies. It is in the alkylating agent class of cytotoxic medications. … http://spc.nam.fi/indox/nam/html/nam/humpil/6/24363046.pdf bodycareworld https://trlcarsales.com

FACHINFORMATION Carboplatin 10 mg/ml Konzentrat zur

WebCisplatin forms part of a group of medicines called cytostatics, which are used in the treatment of cancer. Cisplatin can be used alone but more commonly Cisplatin is used … WebInjectables Products - Accord Healthcare Products Enhancing the pharmaceutical experience for providers and patients. Orals Injectables Topicals Rems Products All Products A B C D E F G H I J K L M N O P … WebOm indlægssedlen 1. Virkning og anvendelse 2. Det skal du vide, før du begynder at bruge Cisplatin Accord 3. Sådan skal du bruge Cisplatin Accord 4. Bivirkninger 5. Opbevaring 6. Pakningsstørrelser og yderligere oplysninger Indehaver af markedsføringstilladelsen og fremstiller Oplysninger tiltænkt læger og sundhedspersonale Revisionsdato bodycare work solutions

CISplatin Accord® Accord Healthcare Switzerland

Category:Cisplatina Accord 1 mg / ml x 1 flacon x 10 ml concentrat pentru ...

Tags:Cisplatin accord fachinfo

Cisplatin accord fachinfo

Cisplatin 1 mg/ml Concentrate for Regulatory ... - Accord …

Web'lh hpsirkohqh 'rvlhuxqj yrq 'rfhwd[ho ehwuljw pj p dov vw qgljh ,qixvlrq jhirojw yrq &lvsodwlq pj p dov elv vw qgljh ,qixvlrq ehlgh qxu dq 7dj jhirojw yrq )oxrurxudflo pj p sur 7dj dov … Web– Cisplatin wird angewendet in Kom-bination mit anderen Chemothera-peutika oder einer Strahlentherapie zur Behandlung des Zervixkarzinoms. – Cisplatin kann als Mono- oder Kombi nationstherapie angewendet werden. 4.2 Dosierung und Art der Anwendung Dosierung Erwachsene und Kinder: Die Cisplatindosis ist abhängig von

Cisplatin accord fachinfo

Did you know?

WebJun 4, 2024 · heart problems--chest pain, irregular heartbeats, swelling in your lower legs, rapid weight gain, feeling lightheaded or short of breath; or low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath. WebPemetrexed Accord in combination with cisplatin The recommended dose of Pemetrexed Accord is 500 mg/m2 of body surface area (BSA) administered as an intravenous infusion over 10 minutes on the first day of each 21-day cycle. The recommended dose of cisplatin is 75 mg/m2 BSA infused over two hours approximately 30 minutes after completion

WebPage 7/10 Safety Data Sheet acc. to OSHA HCS Printing date 09/09/2024 Revision date 09/09/2024 Trade name:Cisplatin (Contd. from page 6) 53.1.21 · Primary irritant effect: · on the skin:No irritant effect. · on the eye:Strong irritant with the danger of severe eye injury. · Sensitization: Sensitization possible through inhalation. WebJun 1, 2024 · A phase 2 trial of durvalumab in combination with gemcitabine and cisplatin demonstrated promising efficacy, with an objective response rate of 72% and a median overall survival of 20.2 months...

WebFind details around Cisplatin from Accord-Healthcare: the evolution of generics.

WebCisplatin Accord injection is a clear, colourless to pale yellow sterile solution of cisplatin 1 mg/mL and sodium chloride 9 mg/mL in water for injections. 4 CLINICAL PARTICULARS …

WebFeb 1, 2003 · Cisplatină Accord se administrează numai prin injectare într-o venă (perfuzie intravenoasă). Echipamentul de asigurare a suportului trebuie să fie disponibil pentru a controla reacţiile anafilactice. Cisplatină Accord nu trebuie să vină în contact cu materiale care conţin aluminiu. body carnaval bebeWebCisplatin United States Pharmacopeia (USP) Reference Standard Synonym (s): cis-Diammineplatinum (II) dichloride, cis-Dichlorodiammine platinum (II), cis-Platinum (II) diammine dichloride, Cisplatin Linear Formula: Pt (NH3)2Cl2 CAS Number: 15663-27-1 Molecular Weight: 300.05 MDL number: MFCD00011623 PubChem Substance ID: … bodycare workplace solutions reviewsWeboder bei mit Cisplatin vorbehandelten Patienten zu. Der Patient sollte neuro-logisch überwacht und in regelmä-ßigen Abständen neurologisch unter-sucht werden. Bei … glass with lines calledWebexperienced nephrotoxicity as a result of cisplatin therapy. The carcinogenic potential of carboplatin has not been studied but compounds with similar mechanisms of action and … body cargoWebNov 30, 2024 · Cisplatin 1mg/ml Injection BP Active Ingredient: cisplatin Company: Sandoz Limited See contact details ATC code: L01XA01 About Medicine Prescription only medicine Healthcare Professionals (SmPC) This information is for use by healthcare professionals Last updated on emc: 30 Nov 2024 Quick Links body caring向ヶ丘遊園Web/de/drugs/4LKkeHTvGRdBw2MF4IGVmoSGOy6/fluorouracil-accord-50-mg-ml-injektions-infusionslosung-20-ml glass with metal frameWeb1. Mitä Cisplatin Accord 1 mg/ml on ja mihin sitä käytetään 2. Mitä sinun on tiedettävä, ennen kuin käytät Cisplatin Accord 1 mg/ml -valmistetta 3. Miten Cisplatin Accord 1 mg/ml -valmistetta käytetään 4. Mahdolliset haittavaikutukset 5. Cisplatin Accord 1 mg/ml -valmisteen säilyttäminen 6. Pakkauksen sisältö ja muuta tietoa 1. body car ferrol